Milbank represented SK bioscience Co. Ltd. in the deal. SK bioscience announced that its board of directors decided to make an equity investment in Novavax, securing...
SK bioscience’s $84.5 Million Equity Investment in Novavax
SK and Geely Automobile’s Launch of New Mobility Investment Fund
Dechert, working alongside Maples and Calder, acted as counsel to SK Inc. for the deal. SK Inc. (formerly SK Holdings) (“SK Inc.”) completed its joint launch...